{"id":1513127,"date":"2024-06-18T10:05:44","date_gmt":"2024-06-18T08:05:44","guid":{"rendered":"https:\/\/laboklin.com\/?page_id=1513127"},"modified":"2026-10-23T18:17:15","modified_gmt":"2026-10-23T16:17:15","slug":"braf-comp-subsequent-demand-2-cna-dog","status":"publish","type":"page","link":"https:\/\/laboklin.com\/en\/products\/pathology\/tumour-genetic-tests\/braf-comp-subsequent-demand-2-cna-dog\/","title":{"rendered":"BRAF Comp. Subsequent Testing (2 CNA) (dog)"},"content":{"rendered":"

BRAF Comp. Subsequent Testing (2 CNA) (dog)<\/h3>

LABOKLIN Service ID: 517<\/span><\/p>


Detection of BRAF variant V595E and detection of copy number
\r\nalterations (CNAs) 13\/19 and 36\/19.

Indications:<\/strong>

  • Urothelial carcinoma (transitional cell carcinoma) after negative BRAF mutation analysis (V595E)<\/li><\/p>
    Material<\/strong><\/td>

    • Urinary sediment (especially early morning urine; fluid + smear) or <\/li>
    • Aspiration cytology (smears) or<\/li>
    • Formalin-fixed, paraffin-embedded tissue (from previous histological examination)<\/li><\/ul> <\/p><\/td><\/tr>
    Method<\/strong><\/td>

    Copy number alteration (CNA) <\/p><\/td><\/tr>

    Species list<\/strong><\/td>

    Dog<\/p><\/td><\/tr>

    Duration<\/strong><\/td>

    2\u20137 working days<\/p><\/td><\/tr>

    Remark<\/strong><\/td>

  • Only a positive result is conclusive.<\/li>
  • Reasons for negative results:<\/li>
      - It is not a urothelial (transitional cell) carcinoma.
      - The carcinoma does not have copy number alterations\/BRAF mutation.
      - There were no or not enough relevant cells present in the sample.
      - There is severe (secondary) inflammation.<\/ul>
    • Testing for CNAs is not suitable for prostate cancer.<\/li>
    • The test cannot be used for cats.<\/li><\/p><\/td><\/tr><\/table>\n","protected":false},"excerpt":{"rendered":"

      BRAF Comp. Subsequent Testing (2 CNA) (dog)LABOKLIN Service ID: 517Detection of BRAF variant V595E and detection of copy number alterations (CNAs) 13\/19 and 36\/19.Indications:Urothelial carcinoma (transitional cell carcinoma) after negative BRAF mutation analysis (V595E)MaterialUrinary sediment (especially early morning urine; fluid + smear) or Aspiration cytology (smears) orFormalin-fixed, paraffin-embedded tissue (from previous histological examination) MethodCopy number…<\/p>\n","protected":false},"author":10,"featured_media":0,"parent":1150000,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1513127","page","type-page","status-publish","hentry","description-off"],"_links":{"self":[{"href":"https:\/\/laboklin.com\/en\/wp-json\/wp\/v2\/pages\/1513127","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/laboklin.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/laboklin.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/laboklin.com\/en\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/laboklin.com\/en\/wp-json\/wp\/v2\/comments?post=1513127"}],"version-history":[{"count":2,"href":"https:\/\/laboklin.com\/en\/wp-json\/wp\/v2\/pages\/1513127\/revisions"}],"predecessor-version":[{"id":1549362,"href":"https:\/\/laboklin.com\/en\/wp-json\/wp\/v2\/pages\/1513127\/revisions\/1549362"}],"up":[{"embeddable":true,"href":"https:\/\/laboklin.com\/en\/wp-json\/wp\/v2\/pages\/1150000"}],"wp:attachment":[{"href":"https:\/\/laboklin.com\/en\/wp-json\/wp\/v2\/media?parent=1513127"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}